Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients

(2009) Christian Walter et al.   CANCER

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies

(2009) T. Fehm et al.   GYNECOLOGIC ONCOLOGY

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan

(2008) C. I. Ripamonti et al.   ANNALS OF ONCOLOGY

Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate

(2008) Christian Walter et al.   EUROPEAN UROLOGY

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

(2008) Ana O Hoff et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates: A Retrospective Study

(2008) T. Ibrahim et al.   ONCOLOGIST

Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies

(2008) Thacharot Boonyapakorn et al.   ORAL ONCOLOGY

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

(2006) Tasuku Mashiba et al.   JOURNAL OF BONE AND MINERAL RESEARCH